top of page
SA Landraces with Cannabis Plants. and species-min.png

Surprise Move as Japan’s Health Ministry Gives the Nod to Legalizing Medical Cannabis

Hemp today

19 October 2022 at 06:00:00

An expert panel studying cannabis issues in Japan has recommended that the country allow for imports of cannabis products for medical use. This comes as some surprise as the Japanese government has traditionally been anti-cannabis, and this could open new doors for African exporters.

Hemp Today reports that Japan’s Ministry of Health, Labor and Welfare has recommended allowing imports of cannabis for medical use, opening a crack for medical grade CBD.

Under the recommendation, prescription-only CBD and other medical cannabis products would be regulated by laws governing pharmaceuticals and medical devices.

The recommendation comes on the advice of an expert panel assigned to study cannabis issues in Japan that included professors and medical professionals, and more than a year after the ministry first indicated its intention to lift the country’s ban on cannabis-based medicines.

Gray market

The health ministry said the policy would align Japan with other countries that already have medical cannabis programs allowing imports and sales under prescription.

Over-the-counter sales of CBD food and cosmetics products remain illegal, but that hasn’t prevented CBD from showing up in retail shops in Japan as producers anxious to reach consumers have sparked a gray market with apparently little response from enforcement agencies.

The country’s over-the-counter CBD industry had an estimated market value of $59 million in 2019, according to Tokyo-based research firm Visiongraph.

Monopolization fears

The Hokkaido Industrial Hemp Association (HIHA) and other hemp stakeholders have said the restrictive policy limiting CBD to medical use means big pharmaceutical firms could control the CBD market. The association has urged the government to go further and draw a clear line between high-

THC marijuana and hemp at 0.3% THC, a generally observed limit around the world although some countries in Latin America and Asia are setting that limit at 1.0%. The limit is important because CBD rises in hemp plants in proportion to THC, making CBD production more efficient.

Hemp for industrial purposes also remains limited pending further changes to the country’s strict Cannabis Control Act, a throwback to the days of the American occupation of Japan following World War II. Under current regulations, based on the notorious U.S. Marijuana Tax Act of 1937, only the stem and seeds of hemp plants may be used to manufacture products, and imports of hemp products made from leaves and flowers are illegal, as are hemp cultivation seed imports. Marijuana is banned outright and severely punished with incarceration.

Stakeholder recommendations

HIHA has urged that industrial hemp be classified according to THC content and end use, with separate regulations developed for each plant component, and treated as a common agricultural product. While those changes have been discussed at the ministry level, the recommendation from health officials, which came late last month, falls far short of the legal revisions that Japanese hemp supporters have long sought.

The study by the expert panel which led to the ministry’s recommendation was released in May 2021. In addition to the advisability of legalizing medical cannabis, the report also addressed the need for treatment for those who abuse cannabis, and how to address youth consumption.


Goodleaf says SAHPRA restrictions on dosages and packaging have pushed it into an uncompetitive corner. It says it's pulling its range off the shelves until there's more regulatory certainty in the cannabis market.

Regulatory Uncertainty Bites SA's Biggest CBD Brand, Goodleaf Temporarily Pulls It Range From The Shelves

For the first time non-government stakeholders in the cannabis industry will have a formal seat at the policy table

The Presidency Unveils New Structure to Align Cannabis Stakeholders on Future Policy

Government has the capacity to invest in strategic parts of the cannabis value chain but says that it's looking to the private sector to cough up most of the cash to kick-start the new sunrise sector.

SA Cannabis Finance ‘Eco-System’: The Phakisa Acknowledges That Private Sector Has to Lead the Way

bottom of page